Literature DB >> 9605395

Medial medullary infarction with restricted sensory symptom.

J S Kim1, J Y Koh, J H Lee.   

Abstract

Sensory abnormalities in patients with medial medullary infarction (MMI) usually involve half of the patient's body and extremities. We report 3 patients with restricted sensory symptoms due to MMI. Patient 1 had sensory symptoms restricted to the contralateral foot secondary to an infarct selectively involving the ventral portion of the medial lemniscus that probably corresponds to leg-representing area. Patient 2 had restricted sensory changes over the contralateral perioral area caused by lesions predominantly involving the posterior part of the medulla that may have affected a part of the ascending trigeminal tract. Patient 3 had sensory symptoms limited to the upper part of his body and the arms (pseudosyringomyelia pattern) due to bilateral MMI that may have resulted from the ventral-dorsal difference in the severity of the lesion. These patients illustrate that restricted sensory abnormalities can occur in patients with MMI. Our MRI-clinical correlation study is consistent with the previously reported sensory topography of the medial lemniscus and the ascending trigeminal tract: the leg-representing area is located ventrally in the medial lemniscus whereas the perioral-representing area is situated most medially in the ascending trigeminal tract.

Entities:  

Mesh:

Year:  1998        PMID: 9605395     DOI: 10.1159/000007929

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  2 in total

1.  Hemi- and monoataxia in cerebellar hemispheres and peduncles stroke lesions: topographical correlations.

Authors:  C Deluca; G Moretto; A Di Matteo; M Cappellari; A Fiaschi; M Tinazzi
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

2.  Medial medullary infarction with central sparing.

Authors:  Davis C Ryman; Yo-El S Ju
Journal:  Neurology       Date:  2013-12-03       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.